[96a5a0]: / output / allTrials / identified / NCT00338182_identified.json

Download this file

155 lines (155 with data), 6.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
{
"info": {
"nct_id": "NCT00338182",
"official_title": "A Phase I, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD1152 Given as a 2-hour or 48-hour Intravenous Infusions in Patients With Advanced Solid Malignancies",
"inclusion_criteria": "* Histological or cytological confirmation of a solid, malignant tumour\n* At least one measurable or non-measurable site of disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 130 Years",
"exclusion_criteria": "* Participation in an investigational drug study within the 21 days prior to therapy or those who have not recovered from the effects of an investigational study drug\n* Recent major surgery within 4 weeks prior to entry into the study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histological or cytological confirmation of a solid, malignant tumour",
"criterions": [
{
"exact_snippets": "Histological or cytological confirmation of a solid, malignant tumour",
"criterion": "solid, malignant tumour",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": [
"histological",
"cytological"
]
}
]
}
]
},
{
"line": "* At least one measurable or non-measurable site of disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) criteria.",
"criterions": [
{
"exact_snippets": "At least one measurable or non-measurable site of disease",
"criterion": "site of disease",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "site"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 130 Years",
"criterions": [
{
"exact_snippets": "maximum age of 130 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 130,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Participation in an investigational drug study within the 21 days prior to therapy or those who have not recovered from the effects of an investigational study drug",
"criterions": [
{
"exact_snippets": "Participation in an investigational drug study within the 21 days prior to therapy",
"criterion": "participation in investigational drug study",
"requirements": [
{
"requirement_type": "time since participation",
"expected_value": {
"operator": "<=",
"value": 21,
"unit": "days"
}
}
]
},
{
"exact_snippets": "those who have not recovered from the effects of an investigational study drug",
"criterion": "recovery from effects of investigational study drug",
"requirements": [
{
"requirement_type": "recovery",
"expected_value": true
}
]
}
]
},
{
"line": "* Recent major surgery within 4 weeks prior to entry into the study",
"criterions": [
{
"exact_snippets": "Recent major surgery within 4 weeks prior to entry into the study",
"criterion": "major surgery",
"requirements": [
{
"requirement_type": "recency",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}